Find a study
Browse recruiting studies near you — free to check, always your choice.
795 studies
Recruiting now, in plain language. Every study is watched over by an independent ethics board.
- Parkinson's disease
Exercise Neuroprotection in Parkinson's Disease
Testing whether exercise changes inflammation in people with Parkinson’s
📍 Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV · Las Vegas, NV · Get directions →
The purpose of this study is to explore the relationships of exercise on inflammation in the body of older adults and people with Parkinson's disease (PD). This is important research for older adults but is especially important for people with PD because neuroinflammation is the main pathological mechanism that is responsible for neuron cell death in this neurodegenerative disease.
- Dementia / Alzheimer's
VR&R: Providing Caregiver Respite by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy
Testing how immersive virtual reality at home affects dementia care
📍 Acclaim Health · Oakville, Ontario · Get directions →
The goal of this interventional trial is to learn about how immersive Virtual Reality (VR) therapy can be used at home by individuals with dementia, with assistance from their informal (e.g., friend/family) caregivers. The main question it aims to answer are: 1.
- Parkinson's disease
Exercise to Improve Sleep in Parkinson's Disease
Testing whether different types of exercise improve sleep in Parkinson’s
📍 Jewish Rehabilitation Hospital · Laval, Quebec · Get directions →
This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects.
- Dementia / Alzheimer's
Genetic Characterization of Movement Disorders and Dementias
Studying genes in people with dementia and movement disorders
📍 National Institute of Aging, Clinical Research Unit · Baltimore, MD · Get directions →
Background: There are two basic types of movement disorders. Some cause excessive movement, some cause slowness or lack of movement.
- Parkinson's disease
Parkinson's Foundation PD GENEration Genetic Registry
Building a central database of genetic data for people with Parkinson’s to support future research
📍 University of Alabama Birmingham · Birmingham, AL · +39 more US sites · Get directions →
Development of a central repository for PD-related genomic data for future research.
- Dementia / Alzheimer's
LEADing Dementia End-of-Life Planning Conversations
Testing conversations to plan end-of-life medical care for people with dementia
📍 University of Utah College of Nursing · Salt Lake City, UT · Get directions →
Advance care planning is important for all adults, but perhaps even more so for the 5.7 million persons with Alzheimer's disease or related dementia (ADRD), due to the progressive and protracted cognitive deterioration associated with the disease process. In the context of ADRD, medical decision-making at the end of life is typically left to one's care partner, who often does not have the knowledge or confidence in their ability to make such decisions.
- Multiple sclerosis (MS)💵 May compensate
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
Testing a new brain PET scan tracer to detect inflammation in multiple sclerosis
📍 Washington University in St. Louis · St Louis, MO · Get directions →
This study involves a Positron Emission Tomography (PET) scan using a new investigational radioactive tracer, \[18F\]-FZTA, to detect inflammation in the brain. The tracer will be tested in healthy younger adults and individuals with Multiple Sclerosis.
- Parkinson's disease
Daily Amino Acid Supplementation for People With Parkinson's Disease
Testing whether a daily amino acid supplement improves nutrition in adults with Parkinson’s disease
📍 University of Connecticut · Storrs, CT · Get directions →
The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase essential amino acids (nutritional status)?
- Dementia / Alzheimer's
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
Testing smart-home sensors and AI to spot dementia-related daily activity changes
📍 University of Missouri · Columbia, MO · Get directions →
The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern.
- DepressionDementia / Alzheimer's
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
Testing brain activity during thinking tasks in people with depression or dementia
📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →
The purpose of this study is to investigate the brain activity associated with cognitive tasks (thinking, reasoning, remembering) in order to understand how the brain works during certain tasks and to improve treatment for diseases like dementia and attention deficit disorders. Cognitive (thinking) impairment may include poor memory function, poor attention span, or psychiatric disorders (ex: ADD, depression).
- Multiple sclerosis (MS)
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Testing whether a full-body electrical stimulation suit is safe and helps people with multiple
📍 Shirley Ryan AbilityLab · Chicago, IL · Get directions →
The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.
- Dementia / Alzheimer's
Nabilone for Agitation in Frontotemporal Dementia
Testing whether taking nabilone by mouth reduces agitation in dementia
📍 University of British Columbia, St Paul's Hospital · Vancouver, British Columbia · Get directions →
The primary goal of this study is to test the hypothesis that oral nabilone treatment will reduce agitation compared with placebo in patients with Frontotemporal Dementia (both behavioural variant frontotemporal dementia and primary progressive aphasia). The study population is defined as patients with probable Frontotemporal Dementia that meet the International Psychogeriatric Association criteria for agitation in cognitive disorders.
- Parkinson's disease
TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
Testing rehabilitation programs to reduce freezing of walking in Parkinson’s
📍 Arizona State University · Tempe, AZ · +1 more US site · Get directions →
The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial. Participants will: * Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise) * Have one-on-one training sessions three times per week for 6 weeks * Perform in-lab assessments before beginning and after completing the study intervention * Use wearable mobility sensors during daily life to measure their walking and balance
- Multiple sclerosis (MS)
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Testing whether a low-level brain electric stimulation device can improve memory word recall in
📍 The University of Texas at Dallas · Richardson, TX · Get directions →
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures.
- Dementia / Alzheimer'sParkinson's disease
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Testing whether a tributyrin supplement helps memory, thinking, and balance in adults with Parkinson
📍 Domino's Farms · Ann Arbor, MI · Get directions →
The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation.
- Dementia / Alzheimer's
Phosphorylated Tau Levels in Donated Blood
Testing how levels of a dementia-related blood protein relate to risk
📍 University of Texas Health Science Center at Houston · Houston, TX · Get directions →
Alzheimer's disease (AD) is characterized by the accumulation of tau pathology, and blood-based biomarkers such as phosphorylated tau-217 (pTau217) have been identified as sensitive and specific predictors of AD risk. Recent studies suggest that individuals with elevated pTau217 levels may be at increased risk for developing AD and cognitive dysfunction.
✓ Study care freeLearn more → - Parkinson's disease
Effects of RAS on Gait in PD Patients With DBS
Testing how rhythm cues affect walking in people with Parkinson’s on and off DBS
📍 Johns Hopkins School of Medicine · Baltimore, MD · Get directions →
Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states.
- Parkinson's disease
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
Testing a non-invasive brain stimulation device to improve Parkinson’s movement problems
📍 U LLC Headquarters · Cleveland, OH · Get directions →
This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.
- Parkinson's disease
Sleep-specific DBS Therapy in Parkinson's Disease
Testing how deep brain stimulation affects sleep problems in Parkinson's
📍 University Of Minnesota · Minneapolis, MN · Get directions →
Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood.
- Parkinson's disease
Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
Testing how personalized touch cues and Parkinson’s medication affect walking in people with
📍 Oregon Health and Science University · Portland, OR · Get directions →
The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait speed).
- Parkinson's disease
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
Testing focused ultrasound on brain function and thinking in Parkinson's
📍 The Regenesis Project · Santa Monica, CA · +1 more US site · Get directions →
This is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.
- Dementia / Alzheimer's
Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease
Testing light and sound stimulation to help prevent dementia in people at risk of Alzheimer’s
📍 Massachusetts General Hospital · Boston, MA · +1 more US site · Get directions →
Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits (amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. Gamma waves are important for memory, and in patients with AD, there are fewer gamma waves in the brain.
- Parkinson's disease
Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
Testing step training with a metronome to improve walking in people with Parkinson disease
📍 University of North Carolina at Chapel Hill · Chapel Hill, NC · Get directions →
The purpose of this research study is to determine how training to step with a metronome on both a treadmill, as well as overground, will influence the way that people with Parkinson disease walk. Using metronomes is commonly used in clinics, but the investigators will be using a combination of slow and fast frequencies to alter the way that people walk.
- Dementia / Alzheimer's
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Studying genetics in families affected by frontotemporal dementia
📍 Western University · London, Ontario · Get directions →
This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.
- Multiple sclerosis (MS)
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Testing remibrutinib in people with relapsing multiple sclerosis who switch from ocrelizumab versus
📍 Perseverance Research Center · Scottsdale, AZ · +39 more US sites · Get directions →
The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple sclerosis (plwRMS).
- Dementia / Alzheimer's
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
Testing 6 months of aerobic exercise to improve fitness in older adults with mild cognitive
📍 Arizona State University · Phoenix, AZ · Get directions →
The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease. The main questions it aims to answer are: * test the effects of aerobic exercise on aerobic fitness, white matter hyperintensity (WMH) volume, and patient-centered outcomes; * identify the best exercise to improve aerobic fitness and reduce non-responses over 6 months; and * examines the mechanisms of aerobic exercise's action on memory in older adults with early AD.
- Dementia / Alzheimer's
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Collecting information on people with dementia receiving anti-amyloid antibody treatment
📍 Georgia Memory Net Memory Assessment Clinic - Albany · Albany, GA · +7 more US sites · Get directions →
The purpose of this registry is to compile information on patients who are receiving FDA-approved anti-amyloid mAbs in the course of their clinic visits in the Emory Cognitive Neurology Clinic and in Georgia Memory Net Memory Assessment Clinics.
- Dementia / Alzheimer's
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Testing the safety and how a drug works in people with Alzheimer’s
📍 Clinical Trial Site · Montreal, · Get directions →
The purpose of this study is to: * Evaluate the safety and tolerability of intrathecal (IT) ALN-5288 in patients with Alzheimer's Disease (AD) * Evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) effects of ALN-5288 after dose administration
- Parkinson's disease
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Testing an experimental treatment for early Parkinson’s disease in adults
📍 Montreal Neurological Institute and Hospital · Montreal, Quebec · Get directions →
This study is researching an experimental drug called ALN-SNCA (called "study drug"). The study is focused on people with early Parkinson's disease, a disorder of the nervous system that affects movement.
- Dementia / Alzheimer's
Evaluating the Effectiveness of the Health App Recommendation Tool
Testing a tool that suggests health apps for people with dementia
📍 University of Pittsburgh · Pittsburgh, PA · Get directions →
This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them to the needs, abilities, and preferences of individuals with Alzheimer's disease and related dementias (ADRD) or their caregivers. This novel tool is not an app in and of itself, but rather an assessment tool used to determine how well suited a given app is for a member of the ADRD or caregiver population.
- Parkinson's disease
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
Testing whether colon tissue can show a protein linked to Parkinson’s and REM sleep behavior
📍 Digestive Disease Associates · Branford, CT · Get directions →
The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease and RBD?
- Multiple sclerosis (MS)
NARCOMS Registry: A Multiple Sclerosis Registry
Tracking people with multiple sclerosis to learn about disease and treatment patterns over time for
📍 UT Southwestern Medical Center · Dallas, TX · Get directions →
This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The information gathered is used for research only.
- Dementia / Alzheimer's
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
Testing a program to improve sleep for nursing home residents with dementia
📍 Vivage/Beecan Corporation · Lakewood, CO · +2 more US sites · Get directions →
This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.
- Parkinson's disease
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
Testing whether a low-dose seizure medicine can help Parkinson’s psychosis
📍 Johns Hopkins · Baltimore, MD · Get directions →
This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks.
- Dementia / Alzheimer's
Tau Networks in Psychotic Alzheimer's Disease
Studying brain processes behind psychotic symptoms in Alzheimer’s dementia
📍 The Feinstein Institutes for Medical Research · Manhasset, NY · Get directions →
This research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the unique relationship with tau pathology. Amongst the cognitive manifestations of psychosis are impairments related to frontal circuits (social cognition, working memory and executive function deficits).
- Parkinson's disease
Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs
Testing how different exercise programs affect movement, fitness, and quality of life in Parkinson’s
📍 University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building · El Paso, TX · +1 more US site · Get directions →
Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely recognized as one of the most effective non-pharmacological treatments to help people with PD maintain function and independence.
- Dementia / Alzheimer's
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Studying sleep and daily rhythm markers in older adults after major surgery, in people with dementia
📍 Massachusetts General Hospital · Boston, MA · Get directions →
The goal of this prospective cohort study is to assess potential differences in sleep biomarkers in older adult patients undergoing major orthopedic surgery. The main questions it aims to answer are: 1.
- Dementia / Alzheimer's
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Testing whether a blood test can find Alzheimer’s causes of dementia in hospital patients
📍 Cumberland Medical Center · Crossville, TN · +5 more US sites · Get directions →
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting?
- Multiple sclerosis (MS)
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Testing the safety and effects on disease and immune cells of one dose of YTB323 in people with
📍 Novartis Investigative Site · Darlinghurst, New South Wales · Get directions →
This is an open-label, multi-center, non-confirmatory study to assess the safety, disease progression, and cellular kinetics following YTB323 administration to 28 participants with non-active Progressive Multiple Sclerosis (PMS). The study design utilizes an ascending single dose design consisting of 3 sentinel cohorts followed by an expansion cohort.
- Multiple sclerosis (MS)
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Testing a new way to track walking function in people with multiple sclerosis using patient-made
📍 University of California, San Francisco · San Francisco, CA · Get directions →
The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly patient-centered, low-burden, low-cost approach.
- Dementia / Alzheimer's
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
Studying brain wave, muscle, and memory changes in dementia
📍 Mayo Clinic Arizona · Scottsdale, AZ · Get directions →
The purpose of this research study is to investigate how the brain, memory, thinking, and motor behavior change both in individuals with movement and/or cognitive disorders, as well as healthy individuals. Researchers will look at measurements of memory, thinking, brain wave and muscle activity, daily functioning, and brain scans to learn more about brain disorders such as Alzheimer disease and Lewy body disease.
- Multiple sclerosis (MS)
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Testing a modified ublituximab treatment for relapsing multiple sclerosis
📍 TG Therapeutics Investigational Trial Site · Birmingham, AL · +34 more US sites · Get directions →
The primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab in participants with relapsing multiple sclerosis (RMS) as measured by T1 Gadolinium (Gd)-enhancing lesions in Part A; PK in Part B along with efficacy of ublituximab as measured by T1 Gd-enhancing lesions in participants who had a suboptimal experience on prior anti-CD20 therapy in Part C. The study consists of 3 parts: Part A is single-armed and open-label, Part B is randomized, double-blind, placebo-controlled, and Part C is single-armed and open-label.
- Dementia / Alzheimer's
Swallowing Impairments in Adults With and Without Alzheimer's Disease
Testing whether adults with Alzheimer’s disease have more swallowing problems than other older
📍 Vanderbilt University Medical Center · Nashville, TN · Get directions →
This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe AD is high (85-93%), yet little is known about how swallow function evolves throughout the disease course in people with AD.
- Parkinson's disease
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Testing a treatment in people with early Parkinson’s disease who have an LRRK2 gene test result
📍 Banner Sun Health Research Institute · Sun City, AZ · +39 more US sites · Get directions →
The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic profile. A DNA test will be used to identify the "LRRK2-driven" population with predicted elevation in the LRRK2 pathway.
- Multiple sclerosis (MS)
A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
Testing how safe ublituximab is for older adults with multiple sclerosis, by tracking infection
📍 Neurology Center of New England P.C. · Foxborough, MA · Get directions →
The purpose of this study is to evaluate the safety of ublituximab use in the older MS adult population, as measured by incidence of infection rate
- Multiple sclerosis (MS)
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Testing safety of a new immune cell therapy in adults with multiple sclerosis
📍 Research Site · Tucson, AZ · +8 more US sites · Get directions →
This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple Sclerosis.
- Parkinson's disease
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
Testing osteopathic treatment to see how it affects leg muscles in Parkinson’s
📍 NYIT College of Osteopathic Medicine · Old Westbury, NY · Get directions →
The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured.
- Multiple sclerosis (MS)
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Testing safety of a twice-yearly medicine for early relapsing MS
📍 Northwestern Memorial Hospital · Chicago, IL · Get directions →
In this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of Ublituximab (Briumvi) twice annually in participants with early MS over a treatment observation period of \~12 months.
- Lupus (SLE)
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
Testing whether adding two lupus medicines to standard care improves kidney results
📍 AARA Clinical Research · Glendale, AZ · +6 more US sites · Get directions →
This is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the proportion of patients with proliferative lupus nephritis achieving complete renal response (CRR) compared to proportion of patients achieving CRR from recent clinical trials. This protocol will additionally determine whether combination therapy using Belimumab (BEL) and Voclosporin (VCS) facilitates rapid discontinuation of MMF.
- Parkinson's disease
A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery
Testing whether implanting a patient’s own nerve tissue during DBS surgery is safe in Parkinson’s
📍 University of Kentucky · Lexington, KY · Get directions →
The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve tissue (PNT) delivery into the NBM or the alternate target also affecting cognition in this population, the substantia nigra (SN), to address "repair cell" support of these areas. Twenty-four participants with idiopathic Parkinson's Disease (PD) who have selected, qualified and agreed to receive as standard of care deep brain stimulation (DBS) will be enrolled and randomly allocated to receive bilateral PNT deployment to either the NBM or SN at the time of DBS surgery.
- Parkinson's disease
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
Comparing lower versus higher amounts of light exercise for Parkinson’s
📍 Atlanta VA Medical and Rehab Center, Decatur, GA · Decatur, GA · Get directions →
Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks.
- Dementia / Alzheimer's💵 May compensate
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
Testing a brain stimulation approach to study memory and thinking in people with early
📍 Massachusetts General Hospital · Charlestown, MA · Get directions →
The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will undergo an EEG and complete some questionnaires and computer tasks during each study visit.
- Dementia / Alzheimer's
Investigating Genetic Status in Patients Presenting to Clinic
Studying genes to understand what causes dementia
📍 Parkwood Institute · London, Ontario · Get directions →
The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified.
- Parkinson's disease
Apathy in Parkinson Disease TMS Study
Testing non-invasive brain stimulation targets for apathy in Parkinson disease
📍 UNC-Chapel Hill, Cassidy Lab · Chapel Hill, NC · Get directions →
The goal of this clinical trial is to develop non-invasive brain stimulation targets for the treatment of apathy, or motivation problems, in Parkinson Disease. The main questions the study aims to answer are: 1.
- Parkinson's disease
Exercise & Brain Energetics in PD
Testing whether exercise changes brain energy use in Parkinson’s disease
📍 Pacific Parkinson's Research Centre · Vancouver, British Columbia · Get directions →
There is increasing evidence that the usage and delivery of energy to the brain, known as brain energetics, is altered in people with Parkinson's disease (PD). This project will explore whether exercise has a positive impact on brain energetics using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) brain scanning in PD subjects.
- Multiple sclerosis (MS)
Effect of Cooling on Balance Performance in Multiple Sclerosis
Studying whether cooling affects balance in people with multiple sclerosis
📍 Hunter College, Physical Therapy Department, City University of New York · New York, NY · Get directions →
The goal of this observational study to examine the effects of cooling on balance in persons with Multiple Sclerosis. Persons with Multiple Sclerosis frequently have problems with balance leading to falls and related injuries, as well as avoidance of activities that may challenge balance.
- Dementia / Alzheimer's
Cognitive Neurology Unit Clinical Registry
Testing monoclonal antibody treatments for Alzheimer’s disease in people with dementia
📍 Beth Israel Deaconess Medical Center · Boston, MA · Get directions →
A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease
- Dementia / Alzheimer's
dTMS for Subjective Cognitive Decline
Testing deep brain magnetic stimulation in people with memory decline
📍 Rotman Research Institute at Baycrest · Toronto, Ontario · Get directions →
Deep transcranial magnetic stimulation (dTMS) is a brain stimulation technique that involves generating a brief magnetic field in a coil that is placed on the scalp. The magnetic field passes through the skull and induces a weak electrical current in the brain that briefly activates neural circuits at the stimulation site.
- Dementia / Alzheimer's
The Impact of Music Intervention on Sleep
Testing whether a 1-month personalized music program improves sleep in people with dementia and
📍 Duke University School of Nursing · Durham, NC · Get directions →
The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b). The secondary purpose of this research project is to examine the mechanism of stress reduction and sustained effects of the music intervention on PLWD and caregiver well-being.
- Dementia / Alzheimer's
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Comparing a hospital care program with a family-involved version to help prevent delirium in older
📍 Saddleback Medical Center · Orange, CA · +6 more US sites · Get directions →
The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following: 1.
- Showing the first 60 of 795. Add filters or a location to narrow down.